Sergey Vladimirovich Balakhonov

Sergey Vladimirovich Balakhonov

Auto-generated profile, based on publicly available information

Sergey Vladimirovich Balakhonov

Irkutsk Antiplague Research Institute of Siberia and Far East of Rospotrebnadzor

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2022 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
VAVasily G Akimkin
Vasily G Akimkin
APA. Yu. Popova
A. Yu. Popova
APA. A. Ploskireva
A. A. Ploskireva
SUSvetlana Ugleva
Svetlana Ugleva
TSTatiana A. Semenenko
Tatiana A. Semenenko
AMA. A. Muradova
A. A. Muradova
Background. The ongoing pandemic of a new coronavirus infection (COVID-19) determines the relevance of the analysis of epidemiological patterns of SARS-CoV-2 spread among the population of the Russian Federation.Aim — study of the manifestations of the epidemic process of COVID-19 in the Russian Federation in 2020–2022.Materials and methods. A retrospective epidemiological analysis of the incidence of COVID-19 in the Russian Federation was carried out from 03/30/2020 to 04/24/2022. The data from the Rospotrebnadzor report No. 970 “Information on cases of infectious diseases in persons with suspected new coronavirus infection”, information portal Stopcoronavirus.rf, etc. were used. The presence of SARS-CoV-2 RNA was confirmed by real-time RT-PCR.Results and discussion. The analysis of the manifestations of the epidemic process of COVID-19 in the Russian Federation in 2020–2022 showed the presence of two stages which differed depending on the influence of the biological factor and the ongoing anti-epidemic measures. There was a pronounced trend in the development of the epidemic process, starting from megacities (Moscow, Moscow region and St. Petersburg), which are major transport hubs and centers of migration activity of the population, to the regions of the Russian Federation. The SARS-CoV-2 pathogenicity has been shown to decrease with each subsequent cycle of the rise in the incidence of COVID-19 against the background of the increased contagiousness of the virus.Conclusion. As a result of the study, risk areas (megacities) and risk groups were identified.
1

24 September 2022 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
VAVasily G Akimkin
Vasily G Akimkin
APA. Yu. Popova
A. Yu. Popova
Kamil F KhafizovKamil F Khafizov
Kamil F Khafizov
DDD. V. Dubodelov
D. V. Dubodelov
SUSvetlana Ugleva
Svetlana Ugleva
ЮСЮ. П. Скрябин
Ю. П. Скрябин
Background. The ongoing pandemic of the novel coronavirus infection (COVID-19) draws attention to the significance of molecular and genetic monitoring of the SARS-CoV-2 spread among the population of the Russian Federation. The aim of the study was to analyze the dynamics of circulation of SARS-CoV-2 genetic variants in Russia.Materials and methods. The analysis of the circulation dynamics for SARS-CoV-2 genetic variants in Russia was carried out, covering the period from 28/12/2020 to 26/6/2022. The analysis included the data from Rospotrebnadzor Report No. 970 "Information about Infectious Diseases in Individuals with Suspected Novel Coronavirus Infection" and the Virus Genome Aggregator of Russia (VGARus). The presence of SARS-CoV-2 RNA was confirmed by the real-time reverse transcription polymerase chain reaction. The primer panels developed at the Central Research Institute of Epidemiology were used for amplification of genomic fragments and the subsequent sequencing.Results and discussion. Using the Russian VGARus platform developed by the Central Research Institute of Epidemiology, we received the data on mutational variability of SARS-CoV-2. By monitoring the circulation of SARS-CoV-2 genetic variants in Russia from 28/12/2020 to 26/6/2022, we found that Delta and Omicron genetic variants prevailed at different stages of the epidemic.Conclusion. The data of molecular and genetic studies are an essential component of epidemiological surveillance, being critically important for making executive decisions aimed at prevention of further spread of SARS-CoV-2 and laying the groundwork for creating new vaccines.
1

24 March 2021 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PDF file
APA. Yu. Popova
A. Yu. Popova
EAE. E. Andreeva
E. E. Andreeva
EBE. A. Babura
E. A. Babura
SBS. V. Balakhonov
S. V. Balakhonov
NBN. S. Bashketova
N. S. Bashketova
ATAreg Artemovich Totolian
Areg Artemovich Totolian
The novel coronavirus (SARS-CoV-2) pandemic, dubbed COVID-19, has become one of the most serious challenges for human populations in the vast majority of countries worldwide. Rapid spreading and increased mortality related to it required new approaches to manage epidemic processes on a global scale. One of such approaches was based on analyzing SARS-CoV-2 seroprevalence associated with COVID-19. Our aim was to summarize the results on assessing seroprevalence to the SARS-CoV-2 nucleocapsid antigen (Nc) in residents from 26 regions of the Russian Federation, carried out during the first wave of the COVID-19 epidemic.Materials and methods. Seroprevalence distribution was examined in 26 model regions of the Russian Federation according to the unified method developed by the Rospotrebnadzor with the participation of the Federal State Institution Saint Petersburg Pasteur Research Institute of Epidemiology and Microbiology. Such approach implied formation of a group of volunteer subjects in model geographic region who were tested by ELISA for anti-Nc serum antibody level in peripheral blood. Analyzed primary data obtained in separate regions were either accepted for publication or released.Results. The current paper finalizes the data obtained in all 26 regions of the Russian Federation. The total SARS-CoV-2 seroprevalence was 19.5 (10.0–25.6)% with the maximum and minimum value found in the Kaliningrad Region and the Republic of Crimea, respectively (50.2% vs. 4.3%). A pattern of age-related seroprevalence distribution indicates insignificant predominance of seroprevalence among subjects of 1–17 years old: 22.1 (13.1–31.8)%. Among COVID-19 convalescents positive for SARS-CoV Nc antibodies it reached 60.0 (40.0–73.3)%. The number of contact persons comprised 6285 subjects or 8.5% of total volunteer cohort, with the level of seroprevalence reaching up to 25.3 (17.95–35.8)%. A direct correlation was revealed between levels of seroprevalence in convalescent and contact volunteers. In addition, the reproductive number for SARS-CoV was calculated comprising 5.8 (4.3–8.5) suggesting that one convalescent subject can infect at least 4 healthy individuals. A high level of asymptomatic forms of COVID-19 among seropositive subjects was confirmed empirically comprising up to 93.6 (87.1–94.9)%.Conclusion. A single cross-sectional study performed during 2020 June–August timeframe allowed to assess pattern of sex- and agerelated COVID-19 seroprevalence for general population in 26 Russian Federation regions. The data obtained may serve as a basis for the longitudinal cohort investigation with serial subject sampling. The timing and duration of study will be determined by dynamics of ongoing COVID-19 epidemic.

27 April 2023 in Problems of Particularly Dangerous Infections
Verified
Journal Article
Open access
PDF file
EAE. I. Andaev
E. I. Andaev
ANA. Ya. Nikitin
A. Ya. Nikitin
MTM. I. Tolmacheva
M. I. Tolmacheva
IZI. D. Zarva
I. D. Zarva
EYE. V. Yatsmenko
E. V. Yatsmenko
SBS. V. Balakhonov
S. V. Balakhonov
The aim of this review is to predict the incidence of tick-borne viral encephalitis (TBVE) in the Russian Federation for 2023 based on analysis of the epidemiological situation on TBVE during 2012–2022. Over the decade, the highest incidence of TBVE was registered in the Siberian, Volga and Ural Federal Districts. In 2022, the Ural Federal District took the second place, the share of the North-Western one decreased by almost two times. Ranking of territories according to the rate of TBVE incidence at the level of constituent entities has made it possible to attribute 16 of them to the group of regions with a high epidemic risk, 14 – to medium epidemic risk, and 18 – to a low epidemic risk. In 2022, the incidence of TBVE in Russia increased by 1.9 times compared to 2021, and amounted to 1.34 0/0000. Despite the increase in the incidence of TBVE in 2022, a significant downward trend has been retained. The rate of infection of ticks removed from humans in 2022 was below the long-term average values. PCR and ELISA were applied for tests. Infection rate of ticks from environmental objects when studied by PCR was higher than the multi-year average values, and lower when studied by ELISA. In 2022, 3.5 million people were immunized against TBVE (vaccinated and revaccinated). Emergency immunoprophylaxis with immunoglobulin covered 24.5 % of the people affected by tick bites (children accounted for 34.3 %). The forecast for TBVE incidence in Russia in 2023 remains favorable. It is expected to be reduced to (0.83±0.298) 0/0000. However, there was not only an increase in the number of TBVE cases, but also the proportion of clinical manifestations of the disease, as well as lethal outcomes among those who suffered from tick bites in 2022. If this pattern holds, the incidence of TBVE in 2023 will be higher than predicted, especially in the constituent entities where the share of individuals with manifest forms among those who suffered from tick bites has increased greatly.

1 March 2016 in Problems of Particularly Dangerous Infections
Verified
Journal Article
Open access
IEIrkutsk Research Anti-Plague Institute of Siberia and Far East
Irkutsk Research Anti-Plague Institute of Siberia and Far East
SBS.V. Balakhonov
S.V. Balakhonov
APA.Yu. Popova
A.Yu. Popova
FWFederal Service For Surveillance In The Sphere Of Consumers Rights Protection And Human Welfare
Federal Service For Surveillance In The Sphere Of Consumers Rights Protection And Human Welfare
AMA.I. Mishchenko
A.I. Mishchenko
VKV.M. Korzun
V.M. Korzun

22 October 2020 in Problems of Particularly Dangerous Infections
Verified
Journal Article
Open access
PDF file
APA. Yu. Popova
A. Yu. Popova
EEE. B. Ezhlova
E. B. Ezhlova
AMA. A. Mel’nIkova
A. A. Mel’nIkova
SBS. V. Balakhonov
S. V. Balakhonov
MCM. V. Chesnokova
M. V. Chesnokova
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Objective of the seroepidemiological study was to determine the level and structure of herd immunity to SARS-CoV-2 among the population of the Irkutsk Region during the period of an increase in the incidence of COVID-19.Materials and methods. The content of antibodies to SARS-CoV-2 was determined by ELISA applying a reagent panel “ELISA anti-SARS-Cov-2 IgG” produced by the State Scientific Center of Applied Microbiology and Biotechnology (Obolensk).Results and discussion. The investigation has revealed that the herd immunity of the total population of Irkutsk Region amounted to 5.8 %. The greatest share of seropositive persons was among the children aged 14–17 (13.8 %) and 1–6 (11.8 %). It has been established that the risk of infection increases by 3.1 times in case of contact with COVID-19 patients. After exposure to COVID-19, antibodies were produced in 56.5 % of the cases. The share of asymptomatic forms among seropositive residents of the Irkutsk Region reached 81.2 %. Consequently, during the chosen period of increased COVID-19 incidence among the population of Irkutsk Region low level of seroprevalence was formed. A significant proportion of asymptomatic forms of infection characterize high intensity of the latently developing epidemic process. The results obtained can be used when organizing preventive measures, including vaccination, and for forecasting morbidity rates.